Who
Michael Egholm
President & CEO
Company insider
Files Form 4 as: President & CEO, Standard BioTools; Director, IsoPlexis; President, BioPharmaceuticals, Pall.
In numbers
- Trades disclosed
- 113
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $3.2M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 10 Jan 2013
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $66K97,627 at $0.672 | filing |
| 20 Aug 2026filed 24 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $65K97,627 at $0.67 | filing |
| 3 Aug 2026filed 4 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $315K362,625 at $0.868 | filing |
| 3 Aug 2026filed 4 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $315K362,625 at $0.87 | filing |
| 20 May 2026filed 22 May 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $98K97,626 at $1.00 | filing |
| 20 May 2026filed 22 May 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $98K97,626 at $1.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code M | —196,513 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $86K95,014 at $0.908 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code M | —196,513 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code M | —196,513 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code M | —196,513 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $86K95,014 at $0.91 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —1,042,373 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,345,340 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,345,340 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —1,042,373 at $0.00 | filing |
| 23 Feb 2026filed 24 Feb 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $76K66,127 at $1.15 | filing |
| 23 Feb 2026filed 24 Feb 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $76K66,127 at $1.15 | filing |
| 20 Nov 2025filed 24 Nov 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $81K63,529 at $1.28 | filing |
| 20 Aug 2025filed 22 Aug 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $70K54,919 at $1.27 | filing |
News
No headline names them, or the companies they trade most, lately.